Algernon Pharmaceuticals Inc (AGNPF)

[GVX808]

Trust me, you're preaching to the choir...

However, maybe you can explain to me the following:

We were seeing regular press releases throughout September and on 10/2 regarding enrollment for Algernon's "Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19".


9/2: 50 out of 150 patients

- 25 enrollments in 20 days -

9/22: 75 out of 150 patients (50% enrollment)

- 25 enrollments in 7 days -

9/29: 100 out of 150 patients

- 13 enrollments in 4 days -

10/2: 113 out of 150 patients (75% enrollment

At that rate, I was easily expecting a 10/6 update at 125 patients, a 90% update (135 patients) on 10/10, and a 100% update by 10/15.

However, now at 25 days later (10/27), we still have no news release updates regarding enrollment since 10/2 at 113? I find this very strange.

If they have continued to enroll patients at the same pace, then I feel like reaching a milestone without a news release were missed opportunities if they are truly interested in increasing the shareprice and gaining market cap without a private placement.

Thoughts?